Longboard Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the pricing of an upsized...

Related Keywords

Ukraine ,Edgewood ,New York ,United States ,Encephalopathies Dees ,Wedbush Pacgrow ,Nasdaq ,Longboard Pharmaceuticals Inc ,Broadridge Financial Solutions ,Cantor Fitzgerald Co ,Exchange Commission ,Longboard Pharmaceuticals ,Hc Wainwright Co ,Citigroup ,Cantor Fitzgerald ,Capital Markets ,Island Avenue ,Epileptic Encephalopathies ,Private Securities Litigation Reform Act ,Middle East ,Markets ,